MYH14 and cardiomyopathy: It has been reported that anti-myosin cross-reacts with the β-adrenergic receptor (β-AR) and triggers cAMP-dependent protein kinase A (PKA) signaling, thus leading to cell death in cardiomyopathies and myocarditis [13, 23].